Position in BHC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$62,019
-$224,931 QoQ
Shares Held
12,580
-76.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#157
of 220 holders
Holding Since
Jun 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BHC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026LAZARD ASSET MANAGEMENT LLC holds $122,207,057 across 17 Drug Manufacturers - Specialty & Generic names. BHC ranks #17 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
945,784 | $67,964,038 | |
| 2 | RDY |
Dr Reddys Laboratories Ltd
|
1,231,678 | $17,847,014 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
91,371 | $15,399,668 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
67,291 | $4,303,259 | |
| 5 | PAHC |
Phibro Animal Health Corp
|
130,438 | $4,095,753 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
34,396 | $3,815,892 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
95,219 | $2,343,339 | |
| 8 | TLRY |
Tilray Brands, Inc.
|
394,715 | $1,772,270 |
All Filings in BHC
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $62,019 | 12,580 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $286,950 | 53,139 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $319,873 | 46,025 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $256,909 | 39,831 | Shares | Sole | 2025-11-14 | |
| 2024-06-30 | $36,522 | 5,240 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $55,596 | 5,240 | Shares | Sole | 2024-07-09 | |
| 2023-12-31 | $45,192 | 5,635 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $51,037 | 6,209 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $49,672 | 6,209 | Shares | Sole | 2023-08-15 | |
| No filing history on record for this holder in this stock. | ||||||